Science Explorer Interactive view Map
Topic · Immunology

Macrophage Migration Inhibitory Factor

Macrophage Migration Inhibitory Factor is a research topic within Immunology. Science Explorer counts 9.7k research works in it since 1952. 18.8% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the role of Macrophage Migration Inhibitory Factor (MIF) in innate immunity, inflammatory responses, atherosclerosis, autoimmune diseases, cancer, cell survival, angiogenesis, and inflammation. The papers explore MIF as a cytokine involved in modulating immune responses, promoting cell survival, regulating inflammatory pathways, and contributing to the pathogenesis of various diseases.

  • Innate Immunity
  • Inflammatory Response
  • Toll-like Receptor
  • Atherosclerosis
  • Cytokine
  • Autoimmune Diseases
  • Cancer
  • Cell Survival
  • Angiogenesis
  • Inflammation
Research works
9.7k
fractional, since 1952
In the world top 10%
1.8k
per year above
Top-10% rate
18.8%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+11%
the tick is no change

Which countries lead Macrophage Migration Inhibitory Factor research?

By volume, China and the United States publish the most (514 and 232 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 514 works
  2. 2 United States 232 works
  3. 3 Germany 57 works
  4. 4 India 54 works
  5. 5 Japan 44 works
  6. 6 South Korea 36 works
  7. 7 Russia 33 works
  8. 8 United Kingdom 29 works
  9. 9 France 29 works
  10. 10 Canada 25 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 48.9%United States: 22.0%Germany: 5.4%India: 5.1%6 others listed: 18.5%49%largest
China514 · 48.9%United States232 · 22.0%Germany57 · 5.4%India54 · 5.1%6 others listed195 · 18.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Macrophage Migration Inhibitory Factor research?

By volume in 2022–2025, Yale University publishes the most Macrophage Migration Inhibitory Factor research, followed by Nanjing Medical University and Sun Yat-sen University.

Who are the leading researchers in Macrophage Migration Inhibitory Factor?

The most-cited researchers publishing on Macrophage Migration Inhibitory Factor include Anil K. Sood.

  1. 1 Anil K. Sood United States 2.6k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Macrophage Migration Inhibitory Factor research done?

The largest centres of Macrophage Migration Inhibitory Factor research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Guangzhou.

Largest cities, 2022–2025

  1. 1 Beijing China 46 works
  2. 2 Guangzhou China 37 works
  3. 3 Shanghai China 36 works
  4. 4 Nanjing China 28 works
  5. 5 Wuhan China 22 works
  6. 6 Hangzhou China 17 works
  7. 7 Changsha China 16 works
  8. 8 Hefei China 14 works
  9. 9 Xi'an China 13 works
  10. 10 Seoul South Korea 13 works

Where it is the local speciality

  1. GuangzhouCN · 36.9 works3.1×
← less than its size predictsmore →

Location quotient: how much more of its research is in Macrophage Migration Inhibitory Factor than the world average.

See Macrophage Migration Inhibitory Factor on the map

Is Macrophage Migration Inhibitory Factor research growing?

Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Macrophage Migration Inhibitory Factor.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.